• Editor’s Pick
  • Investing
  • Economy
  • Stock
  • Politics
Income Researchers
Editor's PickStock

Elon Musk’s Neuralink raises $650 million in fresh capital

by June 3, 2025
June 3, 2025

Elon Musk’s brain tech startup Neuralink has closed a $650 million funding round, the company announced Monday.

ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and other firms participated in the round, according to a press release. Neuralink said the fresh capital will help the company bring its technology to more patients and develop new devices that “deepen the connection between biological and artificial intelligence.”

Neuralink is building a brain-computer interface, or BCI, which is a system that translates brain signals into commands for external technologies.

The company’s first system, called Telepathy, involves 64 “threads” that are inserted directly into the brain. The threads are thinner than a human hair and record neural signals through 1,024 electrodes, according to Neuralink’s website.

The initial aim of the technology is to help patients with severe paralysis restore some independence. As of Monday, five patients have been implanted with Neuralink’s technology, and are able to “control digital and physical devices with their thoughts,” the release said.

Neuralink is currently carrying out four separate clinical trials around its Telepathy system.

BCIs have been studied in academia for decades, and several other companies, including Synchron, Paradromics and Precision Neuroscience, are developing their own systems.

Paradromics on Monday announced it successfully implanted its BCI in a human for the first time.

It’s not clear what devices Neuralink will look to develop next, but Musk has for years espoused grand ambitions for the brain tech startup. He has even claimed that he would be willing to get an implant himself.

One of the capabilities Musk has repeatedly highlighted is the ability to restore vision to blind patients.

Neuralink received a “Breakthrough Device” designation from the U.S. Food and Drug Administration for a device called Blindsight. This designation is granted to medical devices that have the potential to provide improved treatment for debilitating or life-threatening conditions.

In a post on his social media platform X in September, Musk said Blindsight will enable even those who have lost both eyes and their optic nerve to see.

Neuralink still has a long road ahead before it can commercialize these technologies.

This post appeared first on NBC NEWS
previous post
Uber delivery chief Gore-Coty is leaving after almost 13 years at ride-hailing company
next post
White House stands by tax bill after Musk calls it a ‘disgusting abomination’

Related Posts

‘He’s not a big factor’: Trump’s Senate allies...

June 5, 2025

Biden insists ‘I made the decisions’ as Republicans...

June 5, 2025

Trump orders Attorney General to investigate Biden’s autopen...

June 5, 2025

OpenAI tops 3 million paying business users, launches...

June 5, 2025

Elon Musk posts ‘Kill Bill’ meme in latest...

June 4, 2025

Durbin obstruction threat chills Senate as Trump nominees...

June 4, 2025

Elon Musk warpath against Trump’s ‘big, beautiful bill’...

June 4, 2025

Johnson says Republicans ‘don’t have time’ to craft...

June 4, 2025

Nationwide coordinated retail crime crackdown results in hundreds...

June 4, 2025

Elon Musk posts ‘Kill Bill’ meme in latest...

June 4, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Crypto Market Recap: DePIN Market expected to soar, Hong Kong seeks to expand its digital asset market

      June 5, 2025
    • Premier American Uranium to Acquire Nuclear Fuels, Creating One of America’s Largest Pure-Play Uranium Explorers

      June 5, 2025
    • Hempalta Announces Participation in the 2025 Canadian Climate Investor Conference

      June 5, 2025
    • ‘He’s not a big factor’: Trump’s Senate allies dismiss Elon Musk’s calls to ‘kill the bill’

      June 5, 2025
    • Biden insists ‘I made the decisions’ as Republicans investigate White House autopen use

      June 5, 2025

    Archives

    • June 2025 (133)
    • May 2025 (654)
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 incomeresearchers.com | All Rights Reserved

    Income Researchers
    • Editor’s Pick
    • Investing
    • Economy
    • Stock
    • Politics

    Read alsox

    Trump signs agreements with Qatar on defense and...

    May 14, 2025

    Top House Dems say they’ll join GOP to...

    May 14, 2025

    Tim Walz’s post-election listening tour revealed an all-American...

    May 6, 2025